Form 4 for ERAS Erasca, Inc.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0001193125-26-095181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-03-06 | 2026-03-04 | ERAS | Morris Shannon | Chief Medical Off | S - Sale+OE | $15.04 | -20.0K | 0 | -100% | -$300.8K |
| DT | 2026-03-06 | 2026-03-04 | ERAS | Morris Shannon | Chief Medical Off | M - OptEx | $1.70 | +20.0K | 20.0K | New | +$34.0K |
| DT | 2026-03-06 | 2025-03-04 | ERAS | Morris Shannon | Chief Medical Off | M - OptEx | $0.00 | -20.0K | 515.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | S | D | 20,000 | $15.04 | 0 | D | — | — | (F2) This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.10. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2026-03-04 | M | A | 20,000 | $1.70 | 20,000 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-04 | M | D | 20,000 | $0.00 | 515,800 | D | $1.70 · — to 2034-02-04 | 20,000 Common Stock | (F3) 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. |